companyBiotechnology/Computational ChemistryUSA
Schrödinger, Inc.
A developer of computational platforms for drug discovery and materials science.
Schrödinger, Inc. is a New York City-based company that develops computational platforms used in drug discovery and materials science. The company utilizes physics-based computational methods and machine learning to accelerate the discovery process.
Their offerings include a suite of computational chemistry tools such as the Maestro modeling environment, Glide for docking, and FEP+ for free energy perturbation. In addition to providing these tools, Schrödinger maintains its own drug discovery pipeline and collaborates with various pharmaceutical companies.